Klinische Studie

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

NCT: NCT03554356 · ACTIVE_NOT_RECRUITING

NCT-IDNCT03554356

Medizinische Daten: StatusACTIVE_NOT_RECRUITING

Startdatum2018-09-04

SponsorUniversity of North Carolina, Chapel Hill (OTHER)

First posted2018-06-13

Last updated2026-09-14

Kurzzusammenfassung

A multicenter, prospective, single arm, non randomized clinical trial to evaluate the safety and efficacy of the C2 CryoBalloon Focal Ablation System (CbFAS) for the treatment of persistent dysplasia or intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or \<50% eradication of Barrett's Esophagus (BE) after 2 RFA treatments.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.